Stay updated on Biomarker Therapies in Rare Ovarian Tumors Clinical Trial
Sign up to get notified when there's something new on the Biomarker Therapies in Rare Ovarian Tumors Clinical Trial page.

Latest updates to the Biomarker Therapies in Rare Ovarian Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of an older revision reference (v3.2.0), a minor system update that does not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedThe funding status banner about government funding lapses was removed from the page. This change does not affect trial data or study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedThe 'Record History' page now includes a new version entry (46, 2025-09-10) in the list of study record versions. The rest of the page layout and content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.SummaryDifference10%

- Check76 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.2%

- Check90 days agoChange DetectedUpdated to revision v3.0.2 with a new study status for 2025-09-10 and current date 2025-09-11. Replaces the old 3.0.1 revision and removes the 'Back to Top' link.SummaryDifference2%

Stay in the know with updates to Biomarker Therapies in Rare Ovarian Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Therapies in Rare Ovarian Tumors Clinical Trial page.